, Breast Cancer Research Studies, 2005.

D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, Global cancer statistics, CA Cancer J. Clin, vol.55, pp.74-108, 2002.

C. A. Quiet, D. J. Ferguson, R. R. Weichselbaum, and S. Hellman, Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes, J. Clin. Oncol, vol.14, pp.3105-3111, 1996.

J. N. Ingle, V. J. Suman, and C. G. Kardinal, A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma, Cancer, vol.85, pp.1284-1292, 1999.

W. L. Mcguire, Hormone receptors: their role in predicting prognosis and response to endocrine therapy, Semin. Oncol, vol.5, pp.428-433, 1978.

C. K. Osborne, Steroid hormone receptors in breast cancer management, Breast Cancer Res. Treat, vol.51, pp.227-238, 1998.

V. J. Bardou, G. Arpino, R. M. Elledge, C. K. Osborne, and G. M. Clark, Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases, J. Clin. Oncol, vol.21, pp.1973-1979, 2003.

J. S. Ross, J. A. Fletcher, and G. P. Linette, The Her-2 ? neu gene and protein in breast cancer 2003: biomarker and target of therapy, Oncologist, vol.8, pp.307-325, 2003.

R. P. Shiu and B. M. Iwasiow, Prolactin-inducible proteins in human breast cancer cells, J. Biol. Chem, vol.260, pp.11307-11313, 1985.

D. E. Haagensen and G. Mazoujiay, Biochemistry and immunohistochemistry of fluid proteins, Haagensen DE ed. Diseases of the breast, p.474, 1986.

M. A. Watson and T. P. Fleming, Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer, Cancer Res, vol.56, pp.860-865, 1996.

V. Stearns, H. Yamauchi, and D. F. Hayes, Circulating tumour markers in breast cancer: accepted utilities and novel prospects, Breast Cancer Res. Treat, vol.52, pp.239-259, 1998.

K. L. Cheung, C. R. Graves, and J. F. Robertson, Tumour marker measurements in the diagnosis and monitoring of breast cancer, Cancer Treat. Rev, vol.26, pp.91-102, 2000.

F. J. Esteva and G. N. Hortobagyi, Prognostic molecular markers in early breast cancer, Breast Cancer Res, vol.6, pp.109-118, 2004.

M. J. Slade and R. C. Coombes, The clinical significance of disseminated tumour cells in breast cancer, Nat. Clin. Pract. Oncol, vol.4, pp.30-41, 2007.

N. A. Makretsov, D. G. Huntsman, and T. O. Nielsen, Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma, Clin. Cancer Res, vol.10, pp.6143-6151, 2004.

A. El-rehim, D. M. Ball, G. Pinder, and S. E. , High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses, Int. J. Cancer, vol.116, pp.340-350, 2005.

S. K. Gruvberger-saal, H. E. Cunliffe, K. M. Carr, and I. A. Hedenfalk, Microarrays in breast cancer research and clinical practicethe future lies ahead, Endo. Relat. Cancer, vol.13, pp.1017-1031, 2006.

T. L. Colpitts, P. Billing, and E. Granados, Identification and immunohistochemical characterization of a mucin-like glycoprotein expressed in early stage breast carcinoma, Tumour Biol, vol.23, pp.263-278, 2002.

R. J. Miksicek, Y. Myal, P. H. Watson, C. Walker, L. C. Murphy et al., Identification of a novel breast-and salivary gland-specific, mucin-like gene strongly expressed in normal and tumour human mammary epithelium, Cancer Res, vol.62, pp.2736-2740, 2002.

F. Hube, M. Mutawe, E. Leygue, and Y. Myal, Human small breast epithelial mucin: the promise of a new breast tumour biomarker, DNA Cell Biol, vol.23, pp.842-894, 2004.

M. Lacroix, Significance, detection and markers of disseminated breast cancer cells, Endo. Relat. Cancer, vol.13, pp.1033-1067, 2006.

B. Weigelt, P. Verduijn, A. J. Bosma, E. J. Rutgers, H. L. Peterse et al., Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers, Br. J. Cancer, vol.90, pp.1531-1715, 2004.

P. H. Watson, L. Snell, and M. Parisien, The NCIC-Manitoba Breast Tumour Bank: a resource for applied cancer research, CMAJ, vol.155, pp.281-283, 1996.

L. M. Mcshane, D. G. Altman, W. Sauerbrei, S. E. Taube, M. Gion et al., REporting recommendations for tumour MARKer prognostic studies (REMARK), Breast Cancer Res. Treat, vol.100, pp.229-235, 2006.

S. Troup, C. Njue, and E. V. Kliewer, Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer, Clin. Cancer Res, vol.9, pp.207-214, 2003.

O. H. Lowry, N. J. Rosenbrough, A. L. Farr, and R. J. Randall, Protein measurement with the Folin phenol reagent, J. Biol. Chem, pp.265-275, 0193.

I. Gheorghiu, C. Deschenes, M. Blais, F. Boudreau, N. Rivard et al., Role of specific CCAAT ? enhancer-binding protein isoforms in intestinal epithelial cells, J. Biol. Chem, vol.276, pp.44331-44337, 2001.

E. Leygue, L. Snell, and H. Dotzlaw, Mammaglobin, a potential marker of breast cancer nodal metastasis, J. Pathol, vol.189, pp.28-33, 1999.

E. D. Emberley, Y. Niu, C. Njue, E. V. Kliewer, L. C. Murphy et al., Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer, Clin. Cancer Res, vol.9, pp.2627-2631, 2003.

G. P. Skliris, E. Leygue, L. Curtis-snell, P. H. Watson, and L. C. Murphy, Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours, Br. J. Cancer, vol.95, pp.616-626, 2006.

P. Neven, B. Van-calster, and I. Van-den-bempt, Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer, Breast Cancer Res. Treat, 2007.

Y. Gong, K. Yan, and F. Lin, Determination of oestrogenreceptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study, Lancet Oncol, vol.8, pp.203-211, 2007.

A. C. Wolff, E. H. Hammond, and J. R. Schwartz, American Society of Clinical Oncology ? College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer, J. Clin. Oncol, vol.25, pp.118-145, 2007.

A. Haddad, S. Zhang, Z. Leygue, and E. , Psoriasin (S100A7) expression and invasive breast cancer, Am. J. Pathol, vol.155, pp.2057-2066, 1999.

I. Krop, A. Marz, and H. Carlsson, A putative role for psoriasin in breast tumour progression, Cancer Res, vol.65, pp.11326-11334, 2005.

N. M. Brown, T. T. Stenzel, P. N. Friedman, J. Henslee, G. Huper et al., Evaluation of expression based markers for the detection of breast cancer cells, Breast Cancer Res. Treat, vol.97, pp.41-47, 2006.

P. Maruvada, W. Wang, P. D. Wagner, and S. Srivastava, Biomarkers in molecular medicine: cancer detection and diagnosis, Biotechniques, 2005.

, Apr (suppl, pp.9-15

J. Jacquemier, C. Ginestier, and J. Rougemont, Protein expression profiling identifies subclasses of breast cancer and predicts prognosis, Cancer Res, vol.65, pp.767-779, 2005.

C. E. Gillett, R. J. Springall, D. M. Barnes, and A. M. Hanby, Multiple tissue core arrays in histopathology research: a validation study, J. Pathol, vol.192, pp.549-553, 2000.

R. L. Camp, L. A. Charette, D. L. Rimm, D. L. Rimm, R. L. Camp et al., Validation of tissue microarray technologyin breast carcinoma, Review. Exp. Mol. Pathol, vol.80, pp.255-264, 2000.
DOI : 10.1038/labinvest.3780204
URL : https://www.nature.com/articles/3780204.pdf

N. R. Mucci, G. Akdas, S. Manely, and M. A. Rubin, Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogenous protein expression, Hum. Pathol, vol.31, pp.406-414, 2000.

D. G. Rosen, X. Huang, M. T. Deavers, A. Malpica, E. G. Silva et al., Validation of tissue microarray technology in ovarian carcinoma, Mod. Pathol, vol.17, pp.790-797, 2004.
DOI : 10.1038/modpathol.3800120
URL : https://www.nature.com/articles/3800120.pdf